Phencyclidine-like drugs inhibit N-methyl-D-aspartate evoked striatal acetylcholine release and elicit ipsilateral turning in the rat

K. M. Johnson, L. D. Snell

Research output: Contribution to journalArticle

Abstract

We have previously reported that phencyclidine (PCP) is a potent (IC50 = 70 nM) inhibitor of N-methyl-D-aspartate (NMDA) evoked release of 3H-acetylcholine from rat striatal slices. This ability is shared by the σ opiates (±)cyclazocine (CYCL) and N-allylnormetazocine (NANM) as well as ketamine (KET) and etoxadrol (ETOX), drugs with reported ability to displace 3H-PCPP from rat cortical membranes. Here we extend our findings to show the rank order potency of these drugs: PCP=CYCL=ETOX > KET > NANM. The κ opiate, ethylketocyclazocine (EKC) was 70-fold less potent (IC50 = 8.3 μM) while the μ opiate, morphine, had no effect on this response in concentrations up to 30 μM. Comparison of several active/inactive drug pairs, as defined by their affinity for the PCP binding site, revealed a significantly greater inhibitory effect by each active member: m-NH2-PCP > n-NO2-PCP; dexoxadrol > levoxadrol; (-)CYCL > (+)CYCL. When injected systematically into rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, these PCP-like drugs elicit ipsilateral turning with a similar rank order potency and stereoselectivity as that shown for ACh release inhibition. These results suggest that PCP-like drugs may cause ipsilateral turning via an indirect 'anticholinergic' mechanism mediated by striatal PCP/σ receptors.

Original languageEnglish (US)
JournalFederation Proceedings
Volume44
Issue number5
StatePublished - 1985

Fingerprint

Corpus Striatum
Cyclazocine
Phencyclidine
N-Methylaspartate
Opiate Alkaloids
Acetylcholine
Pharmaceutical Preparations
Ketamine
Inhibitory Concentration 50
Phencyclidine Receptors
Ethylketocyclazocine
Oxidopamine
Cholinergic Antagonists
Substantia Nigra
Morphine
Binding Sites
Membranes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Phencyclidine-like drugs inhibit N-methyl-D-aspartate evoked striatal acetylcholine release and elicit ipsilateral turning in the rat. / Johnson, K. M.; Snell, L. D.

In: Federation Proceedings, Vol. 44, No. 5, 1985.

Research output: Contribution to journalArticle

@article{e87a513400b443699439c6108ab8fd6b,
title = "Phencyclidine-like drugs inhibit N-methyl-D-aspartate evoked striatal acetylcholine release and elicit ipsilateral turning in the rat",
abstract = "We have previously reported that phencyclidine (PCP) is a potent (IC50 = 70 nM) inhibitor of N-methyl-D-aspartate (NMDA) evoked release of 3H-acetylcholine from rat striatal slices. This ability is shared by the σ opiates (±)cyclazocine (CYCL) and N-allylnormetazocine (NANM) as well as ketamine (KET) and etoxadrol (ETOX), drugs with reported ability to displace 3H-PCPP from rat cortical membranes. Here we extend our findings to show the rank order potency of these drugs: PCP=CYCL=ETOX > KET > NANM. The κ opiate, ethylketocyclazocine (EKC) was 70-fold less potent (IC50 = 8.3 μM) while the μ opiate, morphine, had no effect on this response in concentrations up to 30 μM. Comparison of several active/inactive drug pairs, as defined by their affinity for the PCP binding site, revealed a significantly greater inhibitory effect by each active member: m-NH2-PCP > n-NO2-PCP; dexoxadrol > levoxadrol; (-)CYCL > (+)CYCL. When injected systematically into rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, these PCP-like drugs elicit ipsilateral turning with a similar rank order potency and stereoselectivity as that shown for ACh release inhibition. These results suggest that PCP-like drugs may cause ipsilateral turning via an indirect 'anticholinergic' mechanism mediated by striatal PCP/σ receptors.",
author = "Johnson, {K. M.} and Snell, {L. D.}",
year = "1985",
language = "English (US)",
volume = "44",
journal = "Federation Proceedings",
issn = "0014-9446",
number = "5",

}

TY - JOUR

T1 - Phencyclidine-like drugs inhibit N-methyl-D-aspartate evoked striatal acetylcholine release and elicit ipsilateral turning in the rat

AU - Johnson, K. M.

AU - Snell, L. D.

PY - 1985

Y1 - 1985

N2 - We have previously reported that phencyclidine (PCP) is a potent (IC50 = 70 nM) inhibitor of N-methyl-D-aspartate (NMDA) evoked release of 3H-acetylcholine from rat striatal slices. This ability is shared by the σ opiates (±)cyclazocine (CYCL) and N-allylnormetazocine (NANM) as well as ketamine (KET) and etoxadrol (ETOX), drugs with reported ability to displace 3H-PCPP from rat cortical membranes. Here we extend our findings to show the rank order potency of these drugs: PCP=CYCL=ETOX > KET > NANM. The κ opiate, ethylketocyclazocine (EKC) was 70-fold less potent (IC50 = 8.3 μM) while the μ opiate, morphine, had no effect on this response in concentrations up to 30 μM. Comparison of several active/inactive drug pairs, as defined by their affinity for the PCP binding site, revealed a significantly greater inhibitory effect by each active member: m-NH2-PCP > n-NO2-PCP; dexoxadrol > levoxadrol; (-)CYCL > (+)CYCL. When injected systematically into rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, these PCP-like drugs elicit ipsilateral turning with a similar rank order potency and stereoselectivity as that shown for ACh release inhibition. These results suggest that PCP-like drugs may cause ipsilateral turning via an indirect 'anticholinergic' mechanism mediated by striatal PCP/σ receptors.

AB - We have previously reported that phencyclidine (PCP) is a potent (IC50 = 70 nM) inhibitor of N-methyl-D-aspartate (NMDA) evoked release of 3H-acetylcholine from rat striatal slices. This ability is shared by the σ opiates (±)cyclazocine (CYCL) and N-allylnormetazocine (NANM) as well as ketamine (KET) and etoxadrol (ETOX), drugs with reported ability to displace 3H-PCPP from rat cortical membranes. Here we extend our findings to show the rank order potency of these drugs: PCP=CYCL=ETOX > KET > NANM. The κ opiate, ethylketocyclazocine (EKC) was 70-fold less potent (IC50 = 8.3 μM) while the μ opiate, morphine, had no effect on this response in concentrations up to 30 μM. Comparison of several active/inactive drug pairs, as defined by their affinity for the PCP binding site, revealed a significantly greater inhibitory effect by each active member: m-NH2-PCP > n-NO2-PCP; dexoxadrol > levoxadrol; (-)CYCL > (+)CYCL. When injected systematically into rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, these PCP-like drugs elicit ipsilateral turning with a similar rank order potency and stereoselectivity as that shown for ACh release inhibition. These results suggest that PCP-like drugs may cause ipsilateral turning via an indirect 'anticholinergic' mechanism mediated by striatal PCP/σ receptors.

UR - http://www.scopus.com/inward/record.url?scp=18244424582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244424582&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:18244424582

VL - 44

JO - Federation Proceedings

JF - Federation Proceedings

SN - 0014-9446

IS - 5

ER -